|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 209/46 | (2006.01) |
| A61K 31/435 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 3134386 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15726362.5 |
| Date of filing the European patent application | 2015-04-22 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-20 |
| (46) | Date of publication of the claims translation | 2020-08-10 |
| (86) | Number | PCT/JP2015/062912 |
| Date | 2015-04-22 |
| (87) | Number | WO 2015/163485 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 2014089585 | 2014-04-23 | JP |
| (72) |
YAMADA, Masami, JP
SUZUKI, Shinkichi, JP
SUGIMOTO, Takahiro, JP
NAKAMURA, Minoru, JP
SAKAMOTO, Hiroki, JP
KAMATA, Makoto, JP
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome Chuo-ku, Osaka- shi, Osaka 541-0045,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Izoindolin-1-ono dariniai kaip cholinerginio muskarininio M1 receptoriaus teigiamo aloesterinio moduliatoriaus aktyvumas, skirtas Alzheimerio ligos gydymui |
| ISOINDOLINE-1-ONE DERIVATIVES AS CHOLINERGIC MUSCARINIC M1 RECEPTOR POSITIVE ALLOESTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASE |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 12 | 289.00 EUR |
| 2027-04-22 |